Cingulate Inc. Adjourns Special Meeting to Enhance Stockholder Voting

Cingulate Inc. Adjourns Special Meeting of Stockholders

Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company specializing in its innovative Precision Timed Release™ (PTR™) drug delivery platform, has announced the adjournment of its Special Meeting of Stockholders to provide additional time for stockholders to participate in voting on significant proposals. The decision to adjourn was made due to the insufficient number of shares present by remote communication or by proxy that would constitute a quorum.

Reasons for Adjournment

The Board of Directors of Cingulate is committed to ensuring that stockholders have the opportunity to voice their opinions on all proposals listed in the proxy statement. By adjourning this meeting, the Company aims to gather a sufficient number of votes to reflect the interests of its stakeholders accurately. The proposals under consideration are deemed beneficial and strategical for enhancing the Company's long-term vision and operational effectiveness.

Meeting Rescheduling Details

The adjourned Special Meeting of Stockholders is now scheduled to take place at 11:00 a.m. Central Time on August 28, 2024. Stockholders will convene virtually at a designated web address to cast their votes. The Company is focused on ensuring every voice is heard, encouraging participation through multiple voting platforms.

Voting Procedures for Stockholders

Stockholders are encouraged to participate by casting their votes live, either by calling the dedicated toll-free number or through the online voting portal established for this purpose. This approach aims to facilitate ease of participation for all stockholders, reflecting Cingulate’s dedication to transparency and engagement.

Importance of Stockholder Participation

Active involvement from stockholders is crucial for making informed decisions about the Company’s future. The interest shown by stakeholders during this meeting will help determine the direction of Cingulate’s strategic initiatives, including ongoing developments in its robust pipeline of pharmaceutical products aimed at addressing conditions like attention deficit/hyperactivity disorder (ADHD).

About Cingulate Inc.

Cingulate Inc. is focused on advancing healthcare solutions through its unique PTR™ drug delivery system, designed to optimize therapeutic effectiveness and simplify medication regimens for patients. While initially targeting ADHD, Cingulate is also exploring additional therapeutic areas, such as anxiety disorders, where their platform can provide significant benefits. This continuous innovation positions Cingulate as a forward-thinking company within the biopharmaceutical landscape.

Contacting Investor Relations

For inquiries related to investor relations, stockholders and interested parties can reach out to:

Thomas Dalton
Vice President, Investor & Public Relations, Cingulate
Email: TDalton@cingulate.com
Phone: 913-942-2301

Matt Kreps
Darrow Associates
Email: mkreps@darrowir.com
Phone: 214-597-8200

Frequently Asked Questions

What prompted Cingulate to adjourn the Special Meeting?

The adjournment was necessary due to an insufficient number of shares present to constitute a quorum, ensuring that all stockholders have the opportunity to vote on key proposals.

When will the rescheduled Special Meeting take place?

The adjourned Special Meeting is scheduled for August 28, 2024, at 11:00 a.m. Central Time.

How can stockholders cast their votes?

Stockholders can vote live by calling a toll-free number or online through a designated voting portal during the meeting.

What are the main proposals being voted on at the meeting?

The main proposals include various strategic initiatives recommended by the Board of Directors that are believed to be in the best interests of Cingulate's stockholders.

Who should stockholders contact for more information?

Stockholders can contact Thomas Dalton or Matt Kreps for inquiries related to investor relations and further information about the Company.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.